Author

Brian Lara

Boston UniversityORCID 0000-0002-4247-105XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

David H. SherriD· 1 shared Jocelyn FimbresiD· 1 shared Megan SnyderiD· 1 shared Mohammed Muzamil KhaniD· 1 shared Sarah A. MazzilliiD· 1 shared Stefano MontiiD· 1 shared Táchira PichardoiD· 1 shared Vinay Kumar DuggineniiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

David H. SherrORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologyThe Journal of ImmunologyPeer-reviewedMar 1, 2025

The Aryl Hydrocarbon Receptor Controls IFNγ-Induced Immune Checkpoints PD-L1 and IDO via the JAK/STAT Pathway in Lung Adenocarcinoma

Megan Snyder, Zhongyan Wang, Brian Lara…·David H. Sherr

This study shows the aryl hydrocarbon receptor (AhR) mediates IFNγ-induced PD-L1 and IDO1 in lung adenocarcinoma via JAK/STAT, leading to immunosuppression and tumor growth.

17 citationstop 2%

mousehuman

𝕏 PostBluesky